双肺移植术中常规使用体外膜氧合的前瞻性观察研究
该单中心前瞻性观察研究纳入159例双肺移植患者,术中统一使用中央静脉-动脉ECMO支持,必要时延长至术后早期。结果显示术后24小时48.4%患者为PGD0,72小时仅1.3%为PGD3,90天死亡率3.1%,2年生存率86%,提示常规术中ECMO可获良好早期移植物功能与中期结局。
要点
- 双肺移植术中常规中央VA-ECMO支持可行,术后24小时48.4%为PGD0。
- 术后72小时仅1.3%患者为PGD3,机械通气中位时间29小时。
- 90天死亡率3.1%,2年生存率86%,中期结局良好。
核心结论
- 双肺移植术中常规使用ECMO可获得优异的早期移植物功能和中期结局,作者主张常规术中应用ECMO。
研究设计与样本
- 所有移植统一在中央静脉-动脉ECMO支持下完成,移植物功能不达标时可延长ECMO至术后早期。
主要发现
- 术后24小时38.4%(n=61)已拔管,48.4%(n=77)为PGD0,4.4%(n=7)为PGD1,3.1%(n=5)为PGD2,2.5%(n=4)为PGD3,3.1%(n=5)因预防性延长ECMO无法分级。
- 术后72小时76.7%(n=122)已拔管,仅1.3%(n=2)为PGD3。
- 机械通气中位时间29小时(四分位距17-58),90天死亡率3.1%,2年生存率86%。
关键数值与推荐
- PGD分级于移植后24、48、72小时评估。
- 移植结束时移植物功能未达既定质量标准者,可将ECMO延长至术后早期。
临床怎么用
- 双肺移植可考虑常规术中中央VA-ECMO支持,并在移植物功能不达标时延长至术后早期。
- 术后24小时近半数患者为PGD0且可早期拔管,提示该策略有助于早期移植物功能恢复。
局限性
- 单中心观察性研究,无对照组,结论推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intraoperative extracorporeal membrane oxygenation (ECMO) is usually reserved to support patients during complex lung transplantation. We hypothesized that a routine application of intraoperative ECMO in all patients improves primary graft function. METHODS: Patients receiving a bilateral lung transplantation between November 2016 and July 2018 at the Medical University of Vienna were included in this prospective, single-center observational study. All transplantations were uniformly performed on central venoarterial ECMO support, with the possibility to extend ECMO into the early postoperative period whenever graft function did not meet established quality criteria at the end of implantation. Primary graft dysfunction (PGD) grades were evaluated at 24, 48, and 72 hours after transplantation. Perioperative complications and survival outcome were assessed. RESULTS: A total of 159 patients were included in the study. At 24 hours post-transplantation, 38.4% (n = 61) of patients were already extubated, 48.4% (n = 77) were classified as PGD0, 4.4% (n = 7) as PGD1, 3.1% (n = 5) as PGD2, 2.5% (n = 4) as PGD3, and 3.1% (n = 5) were "ungradable" due to prophylactic postoperative prolongation of ECMO. At 72 hours after transplantation, 76.7% (n = 122) of the patients were extubated, as opposed to only 1.3% (n = 2) of patients classified as PGD3. The median time of mechanical ventilation was 29 hours (interquartile range, 17-58). The 90-day-mortality was 3.1%, and 2-year survival was 86%. CONCLUSIONS: Routine use of intraoperative ECMO resulted in excellent primary graft function and mid-term outcome in patients undergoing lung transplantation. To the best of our knowledge, the herein measured PGD rates are the lowest reported in the literature to date. Our results advocate a routine intraoperative use of ECMO in bilateral lung transplantation.
引用
- Hoetzenecker K, Benazzo A, Stork T, et al. Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: An observational study. J Thorac Cardiovasc Surg. 2019. PMID: 31932054. doi:10.1016/j.jtcvs.2019.10.155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。